Ann Calby Miller

CIK: 0001771423

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INO

INOVIO PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

INO
INOVIO PHARMACEUTICALS, INC.
May 20, 2026
Award(A)
Common Stock Options
Direct
41.8K shares-
INO
INOVIO PHARMACEUTICALS, INC.
May 20, 2026
Award(A)
Restricted Stock Unit
Direct
34.2K shares-
INO
INOVIO PHARMACEUTICALS, INC.
May 21, 2025
Exercise(M)
Direct
2.2K shares-

		Type	Shares	Price		Ownership
May 20, 2026	INO INOVIO PHARMACEUTICALS, INC.	Award(A) Common Stock Options	41,800	-	-	Direct
May 20, 2026	INO INOVIO PHARMACEUTICALS, INC.	Award(A) Restricted Stock Unit	34,200	-	-	Direct
May 21, 2025	INO INOVIO PHARMACEUTICALS, INC.	Exercise(M)	2,167	-	-	Direct

1-3 of 3 transactions

About Miller Ann Calby

Miller Ann Calby (SEC CIK 0001771423) files insider reports with the SEC as Director of INOVIO PHARMACEUTICALS, INC. (INO).

Signal8 holds 2 ownership filings by Miller Ann Calby, all Form 4s, filed between May 21, 2025 and May 21, 2026. Those filings report 3 transactions, from May 21, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Miller Ann Calby's filings is in PLYMOUTH MEETING, PA.

Recent filings by Miller Ann Calby

May 20, 2026: Grants or awards of INO derivative securities (2 lines, Form 4, code A).
May 21, 2025: Option exercise of INO shares (Form 4, code M).

Other insiders filing for INOVIO PHARMACEUTICALS, INC. (INO)

YARNO WENDY L, Director
Shepard Jay, Director
Weiner David B., Director
Zoth Lota S., Director
DANSEY ROGER D, Director
BENITO SIMON X, Director

How to read Form 4 transaction codes